Reboxetine versus other antidepressive agents for depression

Reboxetine versus other antidepressive agents for depression

BARBUI, Corrado;CIPRIANI, Andrea;
2009-01-01

Abstract

Reboxetine versus other antidepressive agents for depression
amfebutamone; antidepressant agent; citalopram; duloxetine; fluoxetine; fluvoxamine; Hypericum extract; maprotiline; milnacipran; mirtazapine; paroxetine; reboxetine; sertraline; tricyclic antidepressant agent; venlafaxine; bioassay; clinical assessment; Cochrane Library; comparative study; cost of illness; data extraction; diagnostic and statistical manual of mental disorders; drug efficacy; drug tolerability; Hamilton scale; Hypericum; major depression; mental health service; mental patient; monotherapy; outcome assessment; patient selection; practice guideline; quality of life; risk assessment; sensitivity analysis; systematic review; treatment duration; treatment outcome; unspecified side effect
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/339859
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? ND
social impact